Zydus Lifesciences Limited (ZYDUSLIFE) Stock Statistics & Valuation Metrics

Zydus Lifesciences Limited has a market cap or net worth of ₹974.64B. The enterprise value is ₹976.24B.

Zydus Lifesciences Limited has 1,006,234,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zydus Lifesciences Limited’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 32.40%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Zydus Lifesciences Limited had revenue of 232.41B and earned 45.26B in profits. Earnings per share was 44.97.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Zydus Lifesciences Limited pays an annual dividend of ₹11, resulting in a dividend yield of 0.31%

Zydus Lifesciences Limited upcoming earnings date is Aug 6, 2025, TBA (Confirmed).

Zydus Lifesciences Limited as a current ratio of 1.89, with Debt / Equity ratio of 13.41%

In the past 12 months, Zydus Lifesciences Limited has paid 14.12B in taxes.

Zydus Lifesciences Limited EV to EBITDA ratio is 12.84, with an EV/FCF ratio of 17.49.

Zydus Lifesciences Limited has ₹78.08B in cash and marketable securities with ₹32.13B in debt, giving a net cash position of -₹45.95B billion.

Gross margin is 67.63%, with operating margin of 56.89%, and net profit margin of 19.47%.

The average price target for Zydus Lifesciences Limited is ₹1,088.33, which is 11.43% higher than the current price. The consensus rating is Hold